• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

选择性经皮冠状动脉介入治疗中造影剂用量减少与临床因素的关联

Association of less-contrast media with clinical factors in elective percutaneous coronary intervention.

作者信息

Mukai Yasuhiro, Sakakura Kenichi, Yamamoto Kei, Taniguchi Yousuke, Tsukui Takunori, Seguchi Masaru, Wada Hiroshi, Momomura Shin-Ichi, Fujita Hideo

机构信息

Division of Cardiovascular Medicine, Saitama Medical Center, Jichi Medical University, 1-847, Amanuma, Omiya-ku, Saitama, 330-8503, Japan.

出版信息

Heart Vessels. 2020 Feb;35(2):143-152. doi: 10.1007/s00380-019-01473-3. Epub 2019 Jul 20.

DOI:10.1007/s00380-019-01473-3
PMID:31327030
Abstract

Since the amount of contrast media during percutaneous coronary intervention (PCI) is closely related to the exacerbation of renal function, it should be important to reduce the dose of contrast media during PCI. The purpose of this retrospective study was to evaluate the association of less-contrast media with clinical factors in elective PCI. A total of 709 patients were divided into the less-contrast media group (n = 142) and the conventional-contrast media group (n = 567) according to the quintile of total contrast volume. Univariate and multivariate logistic regression analyses were performed to find associations between the clinical variables and the less-contrast media group. The intravascular ultrasound (IVUS) use rate in the study population was considerably high (94.9%). In multivariable logistic regression analysis, an eGFR < 30 mL/min/1.73 m without hemodialysis was significantly associated with the less-contrast media group [odds ratio (OR) 43.73, 95% confidence interval (CI) 14.05-136.09, P < 0.001]. Left main-left anterior descending artery lesion (OR 0.28, 95% CI 0.17-0.48, P < 0.001), bifurcation lesion (OR 0.39, 95% CI 0.16-0.92, P = 0.03), chronic total occlusion (OR 0.22, 95% CI 0.06-0.90, P = 0.03) were inversely associated with the less-contrast media group. In conclusion, complex lesion characteristics were inversely associated with the less-contrast media in elective PCI. Since operators could access patients' renal function before elective procedure, an eGFR < 30 mL/min/1.73 m was most significantly associated with the less-contrast media. Our results suggest the possibility that the amount of contrast media is controllable in current PCI under IVUS-guidance.

摘要

由于经皮冠状动脉介入治疗(PCI)期间造影剂的用量与肾功能恶化密切相关,因此在PCI期间减少造影剂剂量非常重要。这项回顾性研究的目的是评估选择性PCI中较少造影剂用量与临床因素之间的关联。根据总造影剂用量的五分位数,将709例患者分为较少造影剂用量组(n = 142)和传统造影剂用量组(n = 567)。进行单因素和多因素逻辑回归分析,以找出临床变量与较少造影剂用量组之间的关联。研究人群中血管内超声(IVUS)的使用率相当高(94.9%)。在多因素逻辑回归分析中,估算肾小球滤过率(eGFR)<30 mL/min/1.73 m²且未进行血液透析与较少造影剂用量组显著相关[比值比(OR)43.73,95%置信区间(CI)14.05 - 136.09,P < 0.001]。左主干 - 左前降支病变(OR 0.28,95% CI 0.17 - 0.48,P < 0.001)、分叉病变(OR 0.39,95% CI 0.16 - 0.92,P = 0.03)、慢性完全闭塞(OR 0.22,95% CI 0.06 - 0.90,P = 0.03)与较少造影剂用量组呈负相关。总之,在选择性PCI中,复杂病变特征与较少造影剂用量呈负相关。由于术者在择期手术前可以了解患者的肾功能,eGFR < 30 mL/min/1.73 m²与较少造影剂用量的相关性最为显著。我们的结果表明,在当前IVUS引导下的PCI中,造影剂用量是可控的。

相似文献

1
Association of less-contrast media with clinical factors in elective percutaneous coronary intervention.选择性经皮冠状动脉介入治疗中造影剂用量减少与临床因素的关联
Heart Vessels. 2020 Feb;35(2):143-152. doi: 10.1007/s00380-019-01473-3. Epub 2019 Jul 20.
2
Ultra-Low Contrast Percutaneous Coronary Intervention to Minimize the Risk for Contrast-Induced Acute Kidney Injury in Patients With Severe Chronic Kidney Disease.超低对比度经皮冠状动脉介入治疗以降低重度慢性肾脏病患者对比剂诱发急性肾损伤的风险
J Invasive Cardiol. 2019 Jun;31(6):176-182. Epub 2019 Mar 15.
3
Effect of a Contrast Modulation System on Contrast Media Use and the Rate of Acute Kidney Injury After Coronary Angiography.对比调制系统对冠状动脉造影后对比剂使用和急性肾损伤发生率的影响。
JACC Cardiovasc Interv. 2018 Aug 27;11(16):1601-1610. doi: 10.1016/j.jcin.2018.04.007.
4
Impact of Intravascular Ultrasound-Guided Percutaneous Coronary Intervention on Long-Term Clinical Outcomes in Patients Undergoing Complex Procedures.血管内超声指导下经皮冠状动脉介入治疗对复杂手术患者长期临床结局的影响。
JACC Cardiovasc Interv. 2019 Apr 8;12(7):607-620. doi: 10.1016/j.jcin.2019.01.227. Epub 2019 Mar 13.
5
Intravascular ultrasound guidance to minimize the use of iodine contrast in percutaneous coronary intervention: the MOZART (Minimizing cOntrast utiliZation With IVUS Guidance in coRonary angioplasTy) randomized controlled trial.血管内超声引导以减少经皮冠状动脉介入治疗中碘造影剂的使用:莫扎特(冠状动脉成形术中使用血管内超声引导最小化造影剂使用)随机对照试验
JACC Cardiovasc Interv. 2014 Nov;7(11):1287-93. doi: 10.1016/j.jcin.2014.05.024. Epub 2014 Oct 15.
6
Minimizing radiographic contrast administration during coronary angiography using a novel contrast reduction system: A multicenter observational study of the DyeVert™ plus contrast reduction system.使用新型造影剂减少系统在冠状动脉造影期间尽量减少造影剂用量:DyeVert™ 加造影剂减少系统的多中心观察性研究
Catheter Cardiovasc Interv. 2019 Jun 1;93(7):1228-1235. doi: 10.1002/ccd.27935. Epub 2018 Nov 4.
7
Impact of metabolic syndrome on development of contrast-induced nephropathy after elective percutaneous coronary intervention among nondiabetic patients.非糖尿病患者择期经皮冠状动脉介入治疗后代谢综合征对造影剂肾病发生的影响。
Clin Cardiol. 2015 Mar;38(3):150-6. doi: 10.1002/clc.22364.
8
Optical Coherence Tomography-Guided Percutaneous Coronary Intervention With Low-Molecular-Weight Dextran - Effect on Renal Function.光学相干断层成像引导下经皮冠状动脉介入治疗联合低分子右旋糖酐对肾功能的影响。
Circ J. 2020 May 25;84(6):917-925. doi: 10.1253/circj.CJ-20-0093. Epub 2020 Apr 29.
9
CHA2DS2-VASC score as a preprocedural predictor of contrast-induced nephropathy among patients with chronic total occlusion undergoing percutaneous coronary intervention: a single-center experience.CHA2DS2-VASC评分作为慢性完全闭塞患者经皮冠状动脉介入治疗中对比剂肾病的术前预测指标:单中心经验
BMC Cardiovasc Disord. 2019 Mar 29;19(1):74. doi: 10.1186/s12872-019-1060-0.
10
Outcomes of ultra-low contrast percutaneous coronary intervention in patients with advanced chronic kidney disease.超高对比经皮冠状动脉介入治疗在晚期慢性肾脏病患者中的结局。
Catheter Cardiovasc Interv. 2024 Aug;104(2):227-233. doi: 10.1002/ccd.31128. Epub 2024 Jun 26.

引用本文的文献

1
Usefulness of dual-axis rotational coronary angiography in primary percutaneous coronary intervention for patients with ST-elevation myocardial infarction.双轴旋转冠状动脉造影在 ST 段抬高型心肌梗死患者直接经皮冠状动脉介入治疗中的应用价值。
Heart Vessels. 2021 May;36(5):621-629. doi: 10.1007/s00380-020-01738-2. Epub 2020 Dec 4.
2
In-hospital outcomes of angiography versus intravascular ultrasound-guided percutaneous coronary intervention in ST-elevation myocardial infarction patients.ST段抬高型心肌梗死患者血管造影与血管内超声引导下经皮冠状动脉介入治疗的院内结局
J Community Hosp Intern Med Perspect. 2020 Sep 3;10(5):436-442. doi: 10.1080/20009666.2020.1800970.
3

本文引用的文献

1
Frequency and prognostic impact of intravascular imaging-guided urgent percutaneous coronary intervention in patients with acute myocardial infarction: results from J-MINUET.急性心肌梗死患者血管内成像引导下紧急经皮冠状动脉介入治疗的频率及预后影响:J-MINUET研究结果
Heart Vessels. 2019 Apr;34(4):564-571. doi: 10.1007/s00380-018-1285-3. Epub 2018 Nov 2.
2
Determinants of Slow Flow in Percutaneous Coronary Intervention to the Culprit Lesion of Non-ST Elevation Myocardial Infarction.非ST段抬高型心肌梗死罪犯病变经皮冠状动脉介入治疗中慢血流的决定因素
Int Heart J. 2018 Nov 28;59(6):1237-1245. doi: 10.1536/ihj.18-050. Epub 2018 Oct 10.
3
The impact of percutaneous coronary intervention using the novel dynamic coronary roadmap system.
使用新型动态冠状动脉造影系统进行经皮冠状动脉介入治疗的影响。
Heart Vessels. 2020 Mar;35(3):323-330. doi: 10.1007/s00380-019-01502-1. Epub 2019 Sep 14.
Diastolic dysfunction predicts the risk of contrast-induced nephropathy and outcome post-emergency percutaneous coronary intervention in AMI patients with preserved ejection fraction.
舒张功能障碍可预测射血分数保留的急性心肌梗死患者造影剂肾病的风险及急诊经皮冠状动脉介入治疗后的结局。
Heart Vessels. 2018 Oct;33(10):1149-1158. doi: 10.1007/s00380-018-1165-x. Epub 2018 Apr 27.
4
Determinants of high device cost in current percutaneous coronary interventions.当前经皮冠状动脉介入治疗中器械成本高昂的决定因素。
Cardiovasc Revasc Med. 2018 Jul-Aug;19(5 Pt B):607-612. doi: 10.1016/j.carrev.2017.12.007. Epub 2017 Dec 23.
5
Zero Contrast Coronary Intervention Using Intravascular Ultrasound Guidance in a Patient with Allergy to Contrast Medium.在一名对造影剂过敏的患者中使用血管内超声引导进行零造影剂冠状动脉介入治疗。
Tokai J Exp Clin Med. 2016 Sep 20;41(3):152-5.
6
Contrast Utilization During Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From a Contemporary Multicenter Registry.慢性完全闭塞性经皮冠状动脉介入治疗中的造影剂使用:来自当代多中心注册研究的见解
J Invasive Cardiol. 2016 Jul;28(7):288-94.
7
Transradial vs Transfemoral Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction: A Systemic Review and Meta-analysis.经桡动脉与经股动脉经皮冠状动脉介入治疗 ST 段抬高型心肌梗死的系统评价和荟萃分析。
Can J Cardiol. 2016 Jun;32(6):777-90. doi: 10.1016/j.cjca.2015.08.019. Epub 2015 Aug 28.
8
How the Target Hemoglobin of Renal Anemia Should Be.肾性贫血的目标血红蛋白应该是多少。
Nephron. 2015;131(3):202-9. doi: 10.1159/000440849. Epub 2015 Sep 19.
9
Novel risk score of contrast-induced nephropathy after percutaneous coronary intervention.经皮冠状动脉介入治疗后对比剂肾病的新型风险评分
Nephrology (Carlton). 2015 Aug;20(8):544-51. doi: 10.1111/nep.12429.
10
Intravascular ultrasound guidance to minimize the use of iodine contrast in percutaneous coronary intervention: the MOZART (Minimizing cOntrast utiliZation With IVUS Guidance in coRonary angioplasTy) randomized controlled trial.血管内超声引导以减少经皮冠状动脉介入治疗中碘造影剂的使用:莫扎特(冠状动脉成形术中使用血管内超声引导最小化造影剂使用)随机对照试验
JACC Cardiovasc Interv. 2014 Nov;7(11):1287-93. doi: 10.1016/j.jcin.2014.05.024. Epub 2014 Oct 15.